Stay updated on Pembrolizumab in Thymic Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Thymic Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new publication citation was added to Publications, and an erratum citation was removed.
    Difference
    0.1%
    Check dated 2026-03-18T14:39:44.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:50:39.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new publication citation on PD-1 therapy in solid tumors and removed the previous citation.
    Difference
    0.1%
    Check dated 2026-02-25T06:58:34.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. A funding-status notice and the previous v3.4.1 revision were removed; these are administrative updates that do not affect study data or how to use the page.
    Difference
    0.5%
    Check dated 2026-02-11T02:37:13.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2026-02-03T23:47:38.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a glossary and the metadata revision is updated to v3.4.0, with minor capitalization changes in labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-27T23:48:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Thymic Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.